About: http://data.cimple.eu/news-article/42c18e7c1abaa7340e7cb81f88734751a1ad2f15bbdbee60d26a8d1e

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/42c18e7c1abaa7340e7cb81f88734751a1ad2f15bbdbee60d26a8d1e Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	Pharmaceutical firm Sanofi has been charged in France with failure to adequately warn patients and causing injury over an anti-epilepsy drug linked to birth defects following a three-year probe. The French group said in a statement late Monday that prosecutors had decided to move forward on charges of aggravated fraud and unintentionally causing injury. Under the French legal system, the charges do not automatically mean the case will reach a courtroom as prosecutors could decide not to move to trial. The investigation, launched in September 2016 following legal action by victims and their families, sought to determine whether Sanofi misled doctors and patients about the dangers of the drug valproate -- marketed around the world as Depakine, Depakote, Stavzor and other trade names -- and thus caused injuries to patients. Two French government agencies had earlier concluded that Sanofi had not sufficiently warned about known risks to having pregnant women take the drug. Studies found that babies of women who took the medicine while pregnant had an elevated risk -- around 10 percent -- for congenital malformations. The risk for autism and learning difficulties reached as high as 40 percent. Sanofi in its statement welcomed the advancement of the case as "it will be the occasion to demonstrate that it respected its obligation to inform" patients and was transparent about the drug. The firm said it would defend itself vigorously and said valproate remains the primary drug for many forms of epilepsy. Sanofi shares rose in early trading on Tuesday, climbing 0.6 percent to 88.12 euros, but trailed the blue chip CAC 40 index which was up 1.1 percent overall. els-bl/rl/wdb
schema:headline	Sanofi says charged in birth defects case
schema:mentions	Birth defect Fraud Misled (Celine Dion song) Epilepsy Medication French language Autism France Valproate Blue chip (stock market) Sanofi CAC 40
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2020-02-04 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	negative sentiment
http://data.cimple...readability_score	73 (xsd:integer)
http://data.cimple...tology#hasEmotion	anger

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 5 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software